Article
Lee Newcomer, MD, MHA, of Oncology, Genetics and Women's Health for UnitedHealthcare, says the National Comprehensive Cancer Network is transforming genetic testing by utilizing a tool called the NCCN Biomarkers Compendium, which encourages evidence-based decision-making.
Lee Newcomer, MD, MHA, of Oncology, Genetics and Women's Health for UnitedHealthcare, says the National Comprehensive Cancer Network is transforming genetic testing by utilizing a tool called the NCCN Biomarkers Compendium, which encourages evidence-based decision-making.
“There’s a lot of confusion about what tests work and what tests don’t work in pharmacy, at the clinic, and within managed care organizations,” says Dr Newcomer. He adds that the NCCN Biomarkers Compendium’s accessibility and understandability is what makes it a beneficial guide to ensuring the appropriate utilization of genetic testing.
“I think it will help everyone do a little better job of using these tests,” he says.